These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15897996)

  • 1. Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation.
    Nishikawa K; Matsuoka K; Watanabe M; Igai K; Hino K; Hatano K; Yamada A; Abe N; Terunuma D; Kuzuhara H; Natori Y
    J Infect Dis; 2005 Jun; 191(12):2097-105. PubMed ID: 15897996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.
    Nishikawa K; Matsuoka K; Kita E; Okabe N; Mizuguchi M; Hino K; Miyazawa S; Yamasaki C; Aoki J; Takashima S; Yamakawa Y; Nishijima M; Terunuma D; Kuzuhara H; Natori Y
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7669-74. PubMed ID: 12032341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin.
    Nishikawa K; Watanabe M; Kita E; Igai K; Omata K; Yaffe MB; Natori Y
    FASEB J; 2006 Dec; 20(14):2597-9. PubMed ID: 17065223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
    Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and genotypic traits of Shiga toxin-producing Escherichia coli strains isolated from beef cattle from Paraná State, southern Brazil.
    Farah SM; de Souza EM; Pedrosa FO; Irino K; da Silva LR; Rigo LU; Steffens MB; Pigatto CP; Fadel-Picheth CM
    Lett Appl Microbiol; 2007 Jun; 44(6):607-12. PubMed ID: 17576221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands.
    Kitov PI; Sadowska JM; Mulvey G; Armstrong GD; Ling H; Pannu NS; Read RJ; Bundle DR
    Nature; 2000 Feb; 403(6770):669-72. PubMed ID: 10688205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
    Müthing J; Schweppe CH; Karch H; Friedrich AW
    Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution.
    Bielaszewska M; Middendorf B; Köck R; Friedrich AW; Fruth A; Karch H; Schmidt MA; Mellmann A
    Clin Infect Dis; 2008 Jul; 47(2):208-17. PubMed ID: 18564929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of Shiga toxin by Shiga toxin-expressing Escherichia coli (STEC) in broth media: from divergence to definition.
    Rocha LB; Piazza RM
    Lett Appl Microbiol; 2007 Oct; 45(4):411-7. PubMed ID: 17897384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of dialyzer with immobilized glycoconjugate polymers for removal of Shiga-toxin.
    Miyagawa A; Watanabe M; Igai K; Kasuya MC; Natori Y; Nishikawa K; Hatanaka K
    Biomaterials; 2006 Jun; 27(17):3304-11. PubMed ID: 16499963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monovalent Gb3-/Gb2-derivatives conjugated with a phosphatidyl residue: a novel class of Shiga toxin-neutralizing agent.
    Neri P; Tokoro S; Yokoyama S; Miura T; Murata T; Nishida Y; Kajimoto T; Tsujino S; Inazu T; Usui T; Mori H
    Biol Pharm Bull; 2007 Sep; 30(9):1697-701. PubMed ID: 17827723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of the Ridascreen Verotoxin enzyme immunoassay for detection of Shiga-toxin producing strains of Escherichia coli (STEC) from food and other sources.
    Beutin L; Steinrück H; Krause G; Steege K; Haby S; Hultsch G; Appel B
    J Appl Microbiol; 2007 Mar; 102(3):630-9. PubMed ID: 17309611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activatable Shiga toxin 2d (Stx2d) in STEC strains isolated from cattle and sheep at slaughter.
    Tasara T; Bielaszewska M; Nitzsche S; Karch H; Zweifel C; Stephan R
    Vet Microbiol; 2008 Sep; 131(1-2):199-204. PubMed ID: 18417300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues.
    Watanabe M; Igai K; Matsuoka K; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    Infect Immun; 2006 Mar; 74(3):1984-8. PubMed ID: 16495579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes.
    Geelen JM; van der Velden TJ; Te Loo DM; Boerman OC; van den Heuvel LP; Monnens LA
    Nephrol Dial Transplant; 2007 Mar; 22(3):749-55. PubMed ID: 17127697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of rabbit polyclonal sera against Shiga toxins Stx1 and Stx2 for detection of Shiga toxin-producing Escherichia coli.
    Mendes-Ledesma MR; Rocha LB; Bueris V; Krause G; Beutin L; Franzolin MR; Trabulsi LR; Elias WP; Piazza RM
    Microbiol Immunol; 2008 Oct; 52(10):484-91. PubMed ID: 18822082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.
    Bielaszewska M; Friedrich AW; Aldick T; Schürk-Bulgrin R; Karch H
    Clin Infect Dis; 2006 Nov; 43(9):1160-7. PubMed ID: 17029135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of multifunctional peptides expressing both antimicrobial activity and shiga toxin neutralization activity.
    Yamada Y; Miura Y; Sakaki A; Yoshida T; Kobayashi K
    Bioorg Med Chem; 2006 Jan; 14(1):77-82. PubMed ID: 16169733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants of eae and stx genes of atypical enteropathogenic Escherichia coli and non-O157 Shiga toxin-producing Escherichia coli from calves.
    Wani SA; Hussain I; Nabi A; Fayaz I; Nishikawa Y
    Lett Appl Microbiol; 2007 Dec; 45(6):610-5. PubMed ID: 17916128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNX1 and SNX2 mediate retrograde transport of Shiga toxin.
    Utskarpen A; Slagsvold HH; Dyve AB; Skånland SS; Sandvig K
    Biochem Biophys Res Commun; 2007 Jun; 358(2):566-70. PubMed ID: 17498660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.